BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23138287)

  • 1. Biotech crowdfunding paves way for angels.
    Orelli B
    Nat Biotechnol; 2012 Nov; 30(11):1020. PubMed ID: 23138287
    [No Abstract]   [Full Text] [Related]  

  • 2. Ambitious French biotech plan faces EU hurdle.
    Hodgson J
    Nat Biotechnol; 2003 Feb; 21(2):113-4. PubMed ID: 12560821
    [No Abstract]   [Full Text] [Related]  

  • 3. Germany contemplates new biotech tax scheme.
    Mitchell P
    Nat Biotechnol; 2003 Jun; 21(6):587-8. PubMed ID: 12776130
    [No Abstract]   [Full Text] [Related]  

  • 4. New tax credit program aims to revive ailing biotech research.
    Clin Transl Sci; 2010 Oct; 3(5):200. PubMed ID: 21500422
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotechs get $1 billion windfall in R&D tax credits.
    Thiel K
    Nat Biotechnol; 2009 Dec; 27(12):1066. PubMed ID: 20010563
    [No Abstract]   [Full Text] [Related]  

  • 6. The importance of angels in starting a US biotech venture.
    Sohl J
    Nat Biotechnol; 2005 Feb; 23(2):263-4. PubMed ID: 15724275
    [No Abstract]   [Full Text] [Related]  

  • 7. Surprise US election results may boost biotech.
    Fox JL
    Nat Biotechnol; 2002 Dec; 20(12):1176. PubMed ID: 12454655
    [No Abstract]   [Full Text] [Related]  

  • 8. Taiwan biotech buoyed by colossal financings.
    Cyranoski D
    Nat Biotechnol; 2014 Jun; 32(6):508-10. PubMed ID: 24911482
    [No Abstract]   [Full Text] [Related]  

  • 9. Plant biotech bonanza.
    Waltz E
    Nat Biotechnol; 2008 Oct; 26(10):1060. PubMed ID: 18846061
    [No Abstract]   [Full Text] [Related]  

  • 10. Chasing biotech, state by state--winners and losers.
    Wilan KH
    Nat Biotechnol; 2005 Feb; 23(2):175-9. PubMed ID: 15696143
    [No Abstract]   [Full Text] [Related]  

  • 11. Germany biotech gets second chance.
    Sheridan C
    Nat Biotechnol; 2003 Dec; 21(12):1414-5. PubMed ID: 14647310
    [No Abstract]   [Full Text] [Related]  

  • 12. Australian states compete for biotech primacy.
    Norrie C
    Nat Biotechnol; 2002 Aug; 20(8):760. PubMed ID: 12147988
    [No Abstract]   [Full Text] [Related]  

  • 13. The YIC factor.
    Nat Biotechnol; 2005 Oct; 23(10):1187. PubMed ID: 16211041
    [No Abstract]   [Full Text] [Related]  

  • 14. US biotech firms line up for tax credits.
    Ledford H
    Nature; 2010 Jun; 465(7300):854-5. PubMed ID: 20559355
    [No Abstract]   [Full Text] [Related]  

  • 15. Taiwan: Biotech vision.
    Cyranoski D
    Nat Biotechnol; 2003 Apr; 21(4):463-4. PubMed ID: 12665831
    [No Abstract]   [Full Text] [Related]  

  • 16. Funding Medicare.
    Palmer WH
    CMAJ; 1999 Mar; 160(6):777. PubMed ID: 10189412
    [No Abstract]   [Full Text] [Related]  

  • 17. Funding Medicare.
    Aldis JS
    CMAJ; 1999 Mar; 160(6):777; author reply 777-9. PubMed ID: 10189411
    [No Abstract]   [Full Text] [Related]  

  • 18. New law to boost French biotech industry.
    Louët S
    Nat Biotechnol; 1999 Nov; 17(11):1055. PubMed ID: 10545900
    [No Abstract]   [Full Text] [Related]  

  • 19. Doctors, not the public, are winners in federal budget.
    Gleeson M
    Aust Nurs J; 1998 Jun; 5(11):31. PubMed ID: 10639960
    [No Abstract]   [Full Text] [Related]  

  • 20. Canada wins biotech boost of cancer vaccine project.
    Spurgeon D
    Nature; 1997 Jul; 388(6639):214. PubMed ID: 9230418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.